Epithra 50 Injection
Marketer
Glenmark Pharmaceuticals Ltd
Salt Composition
Epirubicin (50mg)
Overview Epithra 50 Injection
Epithra 50 Injection treats various blood, breast, stomach, lung, ovarian, and soft tissue cancers. It also aids in preventing bladder cancer recurrence post-surgery. Administered intravenously by a healthcare professional, it's used alone or in combination chemotherapy. Dosage and frequency are determined by your physician based on your condition and may adjust over time. Strict adherence to your doctor's instructions is crucial; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects might not be apparent for weeks or months; discontinue only under medical supervision. Epithra 50 Injection reduces contraceptive efficacy; reliable birth control is advised for both genders throughout treatment. Common side effects include nausea, thrombocytopenia, alopecia, amenorrhea, pyrexia, and dermatitis. The medication lowers blood cell counts, increasing infection risk, which can be life-threatening. Regular blood tests monitoring blood cell levels, renal, hepatic, and cardiac function are necessary. Before commencing treatment, disclose any liver or heart conditions, and all other medications you're using, as interactions can impact efficacy. Inform your physician of pregnancy or breastfeeding.
Primary Ingredients of Epithra 50 Injection
No text was provided to rewrite.
Uses of Epithra 50 Injection
Malignant neoplasm
Major Benefits of Epithra 50 Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Epithra 50 Injection:
- Low blood platelets
- Nausea
- Hair loss
- Absence of menstrual periods
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Weight loss
- Decreased white blood cell count (neutrophils)
- Hot flashes
- Gastrointestinal inflammation
- Rash
- Low energy
- Eye disorder
How to use Epithra 50 Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Epithra 50 Injection works:
Epithra 50 Injection is a cancer treatment that inhibits topoisomerase II, an enzyme crucial for breast cancer cell DNA replication. This inhibition, combined with the generation of damaging free radicals, leads to DNA disruption, ultimately hindering the proliferation and inducing the death of breast cancer cells.
SAFETY ADVICE
AlcoholUNSAFE
Combining Epithra 50 Injection and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Administering Epithra 50 Injection to pregnant individuals poses a confirmed risk to the fetus. Therefore, its use during pregnancy is contraindicated. Nevertheless, in exceptional, life-threatening circumstances, a physician might deem its use necessary if the potential advantages outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administration of Epithra 50 Injection is contraindicated while breastfeeding due to potential infant toxicity. Studies indicate a risk of harmful effects to the nursing infant.
DrivingUNSAFE
Epithra 50 Injection can induce adverse reactions that might compromise driving ability. Nausea and vomiting, potential side effects of Epithra 50 Injection, may temporarily hinder safe driving.
KidneySAFE IF PRESCRIBED
Epithra 50 Injection is likely safe for individuals with kidney impairment. Existing evidence indicates dose modification of Epithra 50 Injection may be unnecessary in such cases. However, physician consultation is recommended. Reduced dosages might be explored for patients exhibiting serum creatinine levels exceeding 5 mg/dL.
LiverCAUTION
Patients with liver impairment should use Epithra 50 Injection cautiously, potentially requiring dose modification. A physician's consultation is advised. Epithra 50 Injection is contraindicated in individuals with advanced hepatic dysfunction.
What if you forget to take Epithra 50 Injection :
NA
Facts to Know About Epithra 50 Injection
| Label | Value |
|---|---|
| Chemical Type | Anthracycline-based drug |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Cytotoxic alkaloids |
3,018 People bought this recently